Clot removal in pulmonary embolism trial
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests a procedure to remove blood clots from the lungs in people with moderate or severe pulmonary embolism. It may help reduce strain on the heart and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had symptoms of a blood clot in your lungs for 14 days or less.
- A CT scan has confirmed you have a blood clot in your lungs.
- Your condition is considered intermediate or high risk, meaning it is serious but not immediately life-threatening.
- You are 18 years or older.
- You have signs that your heart is working harder than normal due to the clot.
- You are not allergic to the dye used in X-ray scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure to remove blood clots from the lungs using a tube (catheter) to open blocked vessels. It may help people with a sudden pulmonary embolism who are stable enough to undergo the procedure.
This study looks at how your heart and breathing hold up during a minimally invasive procedure to remove a blood clot from your lungs. It aims to understand how to keep patients stable during the procedure.
This trial tests a device that removes blood clots from the lungs in people with a recent pulmonary embolism. It may help improve blood flow and reduce strain on the heart.
This trial tests a device called the FlowTriever to remove blood clots from the lungs in people with a pulmonary embolism that is not too severe. The goal is to see if this treatment can help improve heart function and symptoms without major surgery.
This study tests a new device (AlphaVac) that removes blood clots from the lungs using a thin tube inserted through a vein. It may be an option for people with acute pulmonary embolism who have signs of heart strain or low blood pressure.
This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.
Hear when a new Pulmonary Embolism and Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.